SCHEMBL25091076

SCHEMBL25091076

C#CC(O)(c1ccc(OCCO)cc1)c1ccc(N2CCCOCC2)cc1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
MAPK1 P28482 1/20 0.41
POLB P06746 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
RAB9A P51151 1/20 0.40
ALDH1A1 P00352 4/20 0.39
KCNH2 Q12809 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
USP2 O75604 1/20 0.39
LMNA P02545 1/20 0.39
TSHR P16473 1/20 0.39
HPGD P15428 2/20 0.38
KDM4E B2RXH2 2/20 0.38
GAA P10253 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1813801 0.95 ALDH1A1 (0.42) MAPTSMN1; SMN2MAPK1POLBL3MBTL1
SCHEMBL24605264 0.90 HRH3 (0.49) MAPTSMN1; SMN2ALDH1A1KCNH2HRH3
SCHEMBL15947087 0.85 ALDH1A1 (0.52) MAPTSMN1; SMN2MAPK1POLBL3MBTL1
SCHEMBL27165410 0.85 ALDH1A1 (0.55) MAPTSMN1; SMN2MAPK1POLBL3MBTL1
SCHEMBL9898457 0.85 ALDH1A1 (0.55) MAPTSMN1; SMN2MAPK1POLBL3MBTL1
SCHEMBL15947085 0.82 MAPT (0.48) MAPTSMN1; SMN2MAPK1RAB9AALDH1A1
SCHEMBL24404033 0.82 MAPT (0.42) MAPTSMN1; SMN2MAPK1POLBL3MBTL1
SCHEMBL25954140 0.81 KMT2A (0.41) MAPTSMN1; SMN2MAPK1RAB9AALDH1A1
SCHEMBL24620659 0.80 MAPT (0.47) MAPTSMN1; SMN2MAPK1RAB9AALDH1A1
SCHEMBL4857099 0.80 MAPT (0.52) MAPTSMN1; SMN2MAPK1L3MBTL1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3653615-B1 CHROMENE COMPOUND, CURABLE COMPOSITION COMPRISING SAME, AND OPTICAL ARTICLE COMPRISING CURED PRODUCT FORMED OF CURABLE COMPOSITION TOKUYAMA CORP (JP) 2023-03-01 EP disclosed